Literature DB >> 16081420

Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4.

Xixuan H Collins1, Shawn D Harmon, Terry L Kaduce, Kristine B Berst, Xiang Fang, Steven A Moore, T Verugopal Raju, John R Falck, Neal L Weintraub, Gregg Duester, Bryce V Plapp, Arthur A Spector.   

Abstract

20-Carboxyeicosatetraenoic acid (20-COOH-AA) is a bioactive metabolite of 20-hydroxyeicosatetraenoic acid (20-HETE), an eicosanoid that produces vasoconstriction in the cerebral circulation. We found that smooth muscle (MSMC) and endothelial (MEC) cultures obtained from mouse brain microvessels convert [3H]20-HETE to 20-COOH-AA, indicating that the cerebral vasculature can produce this metabolite. The [3H]20-COOH-AA accumulated primarily in the culture medium, together with additional radiolabeled metabolites identified as the chain-shortened dicarboxylic acids 18-COOH-18:4, 18-COOH-18:3, and 16-COOH-16:3. N-Heptylformamide, a potent inhibitor of alcohol dehydrogenase (ADH), decreased the conversion of [3H]20-HETE to 20-COOH-AA by the MSMC and MEC and also by isolated mouse brain microvessels. Purified mouse and human ADH4, human ADH3, and horse liver ADH1 efficiently oxidized 20-HETE, and ADH4 and ADH3 were detected in MSMC and MEC by Western blotting. N-Heptylformamide inhibited the oxidation of 20-HETE by mouse and human ADH4 but not by ADH3. These results demonstrated that cerebral microvessels convert 20-HETE to 20-COOH-AA and that ADH catalyzes the reaction. Although ADH4 and ADH3 are expressed in MSMC and MEC, the inhibition produced by N-heptylformamide suggests that ADH4 is primarily responsible for 20-COOH-AA formation in the cerebral microvasculature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081420     DOI: 10.1074/jbc.M504055200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation.

Authors:  Dominik N Muller; Cosima Schmidt; Eduardo Barbosa-Sicard; Maren Wellner; Volkmar Gross; Hantz Hercule; Marija Markovic; Horst Honeck; Friedrich C Luft; Wolf-Hagen Schunck
Journal:  Biochem J       Date:  2007-04-01       Impact factor: 3.857

Review 2.  Conflicting roles of 20-HETE in hypertension and renal end organ damage.

Authors:  Chao Zhang; George W Booz; Qing Yu; Xiaochen He; Shaoxun Wang; Fan Fan
Journal:  Eur J Pharmacol       Date:  2018-06-07       Impact factor: 4.432

3.  Contribution of liver alcohol dehydrogenase to metabolism of alcohols in rats.

Authors:  Bryce V Plapp; Kevin G Leidal; Bruce P Murch; David W Green
Journal:  Chem Biol Interact       Date:  2015-01-29       Impact factor: 5.192

Review 4.  Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

Authors:  Fan Fan; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

Review 5.  Sjögren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency.

Authors:  William B Rizzo
Journal:  Mol Genet Metab       Date:  2006-09-22       Impact factor: 4.797

6.  Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events.

Authors:  Jun-Yan Liu; Ning Li; Jun Yang; Nan Li; Hong Qiu; Ding Ai; Nipavan Chiamvimonvat; Yi Zhu; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

7.  Ethanol at low concentrations protects glomerular podocytes through alcohol dehydrogenase and 20-HETE.

Authors:  Ellen T McCarthy; Jianping Zhou; Ryan Eckert; David Genochio; Rishi Sharma; Olurinde Oni; Alok De; Tarak Srivastava; Ram Sharma; Virginia J Savin; Mukut Sharma
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-11-04       Impact factor: 3.072

8.  Contrasting vascular effects caused by loss of Bardet-Biedl syndrome genes.

Authors:  Andreas M Beyer; Deng-Fu Guo; Val C Sheffield; Kamal Rahmouni
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

Review 9.  20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension.

Authors:  Jan M Williams; Sydney Murphy; Marilyn Burke; Richard J Roman
Journal:  J Cardiovasc Pharmacol       Date:  2010-10       Impact factor: 3.105

Review 10.  Alcohol and Hypertension-New Insights and Lingering Controversies.

Authors:  Ian B Puddey; Trevor A Mori; Anne E Barden; Lawrence J Beilin
Journal:  Curr Hypertens Rep       Date:  2019-09-07       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.